PROC - רווח נקי למניה (EPS TTM) Procaps Group

Management relies on stable demand in the medical sector, creating a defensive asset insulated from macroeconomic fluctuations. Earnings per share over the last 12 months demonstrate the results of this strategy, where 0.66 records a new level. The Colombian CDMO leader, Procaps Group S.A. (PROC), is implementing unique substance delivery methods, while high scalability through mass production for global brands ensures the payback of engineering costs.

Logistics optimization for encapsulated drugs in Latin America provides Procaps Group S.A. (PROC) with high operational efficiency. The EPS TTM metric is calculated as the ratio of total annual net income to the number of shares outstanding. It determines the real return on a single share of capital, adjusted for the impact of issuance. Investors use this indicator to assess the fundamental value of the business. Analyzing the trailing twelve-month earnings per share slice on GURU.Markets helps identify whether the asset is overbought.